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Fragrances and Health
The article "Scents & Sensitivity" [EHP
106:A594-A599 (1998)] provides a good
summary ofthe issues involved in concerns
and controversies over fragranced products.
However, several points should be
addressed.
The health effects of fragrances are a
general health issue, an indoor air quality
issue, an access issue, and an environmental
issue. Unfortunately, the only issue the fra-
grance industry has addressed is that ofskin
safety for the user of the products. This
leaves many areas ofconcern.
Allergic disease affects 20% ofthe popu-
lation and is the sixth leading cause of
chronic disease. There are an estimated 17
million asthmatics, and migraine headaches
affect as many as 25 million people in the
United States. Individuals with nonallergic
rhinitis, chronic respiratory disease, and
chemical sensitivities should also be includ-
ed in these numbers. Fragrances are known
to trigger and exacerbate all of these condi-
tions. The impact offragrances on health is
a general health issue.
Fragrance chemicals are volatile by
nature. This means some ofeach fragranced
product used ends up in the air. The result
is complex mixture ofchemicals that is con-
stantly changing. Fragrance chemicals are
often air, heat, and light sensitive. Very
often the compounds that result from the
reactions and breakdown that occurs in the
air are more irritating than the original
compounds. In indoor environments where
air exchange is poor, the problems are com-
pounded.
Fragrance chemicals are not removed
from wastewater by present sewage treat-
ment methods. Synthetic musk compounds
are being found in waterways and in aquatic
wildlife. The implications are not known
because so little research has been done in
the area of fragrance chemical safety. These
materials are now in the food chain.
The main focus of safety testing in the
fragrance industry has been adverse skin
effects. Fragrance materials penetrate the
skin, are absorbed into the bloodstream, and
are distributed to other organs. Other routes
of exposure, such as respiratory and neuro-
logic exposure via olfactory pathways, have
been ignored. Ingestion is another route of
exposure because many of the same materi-
als are used as flavors in foods.
There are legitimate concerns about the
scope and effectiveness of safety testing by
the fragrance industry. In the late 1970s it
was found that acetylethyltetramethylte-
tralin (AETT) caused the internal organs of
laboratory animals to turn blue. This sub-
stance was also severely neurotoxic. Testing
by the industry had not pinpointed these
side effects, which were discovered by acci-
dent after the material had been used in
products for over 20 years (1,2).
Musk ambrette was also used in fra-
grances for years. Testing by the Research
Institute for Fragrance Materials indicated
that it was safe for use. It was later deter-
mined that musk ambrette caused photosen-
sitivity reactions and had neurotoxic proper-
ties (3). The International Fragrance
Association recommended in 1985 that
musk ambrette not be used in products with
skin contact. In 1991, musk ambrette was
still being found in products tested by the
Food and DrugAdministration (FDA).
More recent concerns are being focused
on musk xylol, which was used to replace
musk ambrette. Safety testing by the indus-
try indicated that musk xylol was safe for
use. Later studies outside the industry found
musk xylol to be carcinogenic when fed to
mice. Musk xylol has been used since the
turn of the century. It accumulates in
human tissue and has been found in human
adipose tissue and breast milk.
Some fragrance materials are known to
act as haptens in the skin. Although there is
significant respiratory exposure to these
materials, the possibility of respiratory sensi-
tization has not been addressed. In some
individuals with asthma, fragrances are pri-
mary triggers, whereas other irritants do not
initiate a response. This suggests that there
may be respiratory sensitization involved. If
fragrance materials have the ability to sensi-
tize the respiratory system in the same man-
ner as the skin, the implications are serious
anid could be one factor in the unexplained
increase in asthma rates.
The fragrance industry asserts that ade-
quate safety testing is done, there is adequate
monitoring of problems, and no increase in
complaints concerning fragranced products
has been noted. The present system ofmon-
itoring complaints is totally inadequate. The
FDA's system of logging complaints is set
up for users of the products, and not for
those made ill by others' use. Someone who
calls the general FDA complaint line may
not be given instructions on whom to con-
tact. Any complaints on "secondhand" fra-
grance should be addressed specifically to
Lark Lambert, HFS-106, Office of
Cosmetics and Colors, Cosmetic Adverse
Reaction Monitoring Program, 200C Street
S.W., Washington, DC 20204 USA.
Telephone: (202) 205-4706. Fax: (202)
205-5098.
Even with the limited method of col-
lecting data, there was an increase in
records of complaints from 1995 to 1997.
These complaints included respiratory and
neurologic effects. The FDA suspended the
Voluntary Cosmetic Registration Program
in March 1998 because of budget cuts; it
was reinstated 1 January 1999. This pro-
gram is totally voluntary, and the industry
is not required to participate.
The FDA only addresses the safety of
materials in cosmetics. Fragrances in house-
hold products come under the jurisdiction
of the Consumer P'roduct Safety
Commission. Once the products volatilize,
air quality falls under U.S. Environmental
Protection Agency jurisdiction. The fra-
grance industry does not have a centralized
data collection program in place. This
means that there is no method in place for
accurately collecting data on the negative
impact offragrances.
The "trade-secret" status of fragrances
makes it difficult, if not impossible, to pin-
point substances that cause problems.
Present labeling is misleading, as "fragrance-
free" and "unscented" products often con-
tain fragrance chemicals. Avoidance is not
possible when labeling does not reflect the
contents.
It seems to be the industry's position to
discount complaints concerning fragrances as
reactionary and psychological responses to
odors. Fragrances do enhance our lives, just
as music does. But taste in music varies-
what is music to one may be noise to anoth-
er. Also, when there is too much noise or
noise is too loud, real health problems occur.
When types of substances used by the
fragrance industry are used in other indus-
tries, they are heavily regulated because of
their known health effects. Whereas these
substances are generally used at low levels in
fragrance materials, the sheer numbers of
fragranced products used and the constant
exposure causes concern, especially in chil-
dren. In addition, many of the materials
have synergistic effects that cannot be
ignored. A much more prudent course of
action would be to gather reliable data, do
further safety testing, pinpoint the sub-
stances causing problems, and eliminate
them from use. Further information can be
found at the web site of the Fragranced
Products Information Network (http://
www.ameliaww.com/fpin/fpin.htm).
Betty Bridges
Fragranced Products Information Network
Amelia, Virginia
E-mail: bcb56@ix.netcom.com
REFERENCES AND NOTES
1. Spencer PS, Sterman AB, Horoupian DS, Foulds MM.
Neurotoxic fragrance produces ceroid and myelin
disease. Science 204:633-635 (1979).
2. Troy WR. Toxicity of Versalide [letterl. Food Chem
Toxicol 20:629 (1982).
3. Wisneski HS, Havery DC. Nitro musks in fragrance
products: an update of FDA findings. Cosmetics and
Toiletries 3(61:73-74 (1996).
A 340 Volume 07, Number 7, July 1999 * Environmental Health Perspectives